SENSUS HEALTHCARE INC (SRTS) Stock Analyst Earnings Estimates
NASDAQ:SRTS - Nasdaq - US81728J1097 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.04M 182.25% | 44.53M 64.68% | 24.405M -45.19% | 40.277M 65.04% | 50.292M 24.87% | 67.253M 33.73% | 75.221M 11.85% | |
| EBITDA YoY % growth | 4.73M 162.90% | 15.15M 220.30% | -107K -100.71% | 8.345M 7,899.07% | 15.16M 81.67% | 27.707M 82.76% | 52.181M 88.33% | |
| EBIT YoY % growth | 4.12M 150.00% | 14.83M 259.95% | -382K -102.58% | 8.914M 2,433.51% | 13.651M 53.14% | 20.54M 50.47% | 25.623M 24.75% | |
| Operating Margin | 15.24% | 33.30% | -1.57% | 22.13% | 27.14% | 30.54% | 34.06% | |
| EPS YoY % growth | 0.24 148.00% | 0.68 183.33% | 0.03 -95.59% | 0.44 1,362.00% | 0.65 48.84% | 0.93 42.71% | 1.14 22.63% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.12 -52.92% | 0.12 -12.57% | 0.14 37.70% | 0.14 100.36% | 0.26 113.89% | 0.06 -50.00% | 0.10 -25.93% | 0.06 -56.36% | 0.14 -45.46% |
| Revenue Q2Q % growth | 10.972M -12.69% | 10.823M 1.50% | 11.391M 23.29% | 11.461M 29.66% | 15.586M 42.05% | 9.18M -15.18% | 9.894M -13.14% | 8.976M -21.68% | 11.628M -25.39% |
| EBITDA Q2Q % growth | 1.491M -74.52% | 2.613M -11.63% | 3.232M 55.16% | 3.839M 132.81% | 5.474M 267.14% | 1.428M -45.35% | 2.142M -33.73% | 1.428M -62.80% | 3.06M -44.10% |
| EBIT Q2Q % growth | 2.413M -56.73% | 2.44M -15.48% | 3.166M 59.74% | 3.337M 123.21% | 6.108M 153.13% | 1.224M -49.84% | 1.938M -38.79% | 1.326M -60.26% | 2.958M -51.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.07 177.78% | -0.01 | 0.08 | 786.27% |
| Q2 2024 Q2Q % growth | 0.10 600.00% | 0.02 | 0.08 | 320.23% |
| Q1 2024 Q2Q % growth | 0.14 216.67% | -0.06 | 0.20 | 349.55% |
| Q4 2023 Q2Q % growth | 0.26 52.94% | 0.12 | 0.14 | 108.94% |
| Q3 2023 Q2Q % growth | -0.09 -181.82% | -0.02 | -0.07 | -390.20% |
| Q2 2023 Q2Q % growth | -0.02 -109.52% | -0.08 | 0.06 | 74.20% |
| Q1 2023 Q2Q % growth | -0.12 -163.16% | 0.13 | -0.25 | -191.91% |
| Q4 2022 Q2Q % growth | 0.17 -46.88% | 0.23 | -0.06 | -27.54% |
| Q3 2022 Q2Q % growth | 0.11 1,000.00% | 0.13 | -0.02 | -14.41% |
| Q2 2022 Q2Q % growth | 0.21 1,150.00% | 0.13 | 0.08 | 55.97% |
| Q1 2022 Q2Q % growth | 0.19 371.43% | 0.34 | -0.15 | -43.55% |
| Q4 2021 Q2Q % growth | 0.32 1,500.00% | 0.17 | 0.15 | 91.30% |
| Q3 2021 Q2Q % growth | 0.01 107.14% | -0.02 | 0.03 | 158.81% |
| Q2 2021 Q2Q % growth | -0.02 87.50% | -0.06 | 0.04 | 64.35% |
| Q1 2021 Q2Q % growth | -0.07 68.18% | -0.10 | 0.03 | 30.21% |
| Q4 2020 Q2Q % growth | 0.02 -66.67% | -0.11 | 0.13 | 117.56% |
| Q3 2020 Q2Q % growth | -0.14 -250.00% | -0.14 | 0.00 | -1.67% |
| Q2 2020 Q2Q % growth | -0.16 -1,700.00% | -0.18 | 0.02 | 12.85% |
| Q1 2020 Q2Q % growth | -0.22 -69.23% | -0.07 | -0.15 | -215.65% |
| Q4 2019 Q2Q % growth | 0.06 | 0.03 | 0.03 | 107.64% |
| Q3 2019 Q2Q % growth | -0.04 | -0.03 | -0.01 | -17.66% |
| Q2 2019 Q2Q % growth | 0.01 | -0.05 | 0.06 | 119.06% |
| Q1 2019 Q2Q % growth | -0.13 | -0.03 | -0.10 | -271.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 8.839M 126.76% | 6.013M | 2.826M | 47.00% |
| Q2 2024 Q2Q % growth | 9.239M 104.09% | 7.142M | 2.097M | 29.36% |
| Q1 2024 Q2Q % growth | 10.663M 212.33% | 4.202M | 6.461M | 153.76% |
| Q4 2023 Q2Q % growth | 12.566M -4.08% | 11.281M | 1.285M | 11.39% |
| Q3 2023 Q2Q % growth | 3.898M -56.74% | 6.002M | -2.104M | -35.05% |
| Q2 2023 Q2Q % growth | 4.527M -62.52% | 4.641M | -114K | -2.46% |
| Q1 2023 Q2Q % growth | 3.414M -66.98% | 10.336M | -6.922M | -66.97% |
| Q4 2022 Q2Q % growth | 13.1M 0.54% | 13.241M | -141K | -1.06% |
| Q3 2022 Q2Q % growth | 9.01M 62.93% | 9.729M | -719K | -7.39% |
| Q2 2022 Q2Q % growth | 12.08M 122.88% | 9.747M | 2.333M | 23.94% |
| Q1 2022 Q2Q % growth | 10.34M 236.81% | 6.867M | 3.473M | 50.58% |
| Q4 2021 Q2Q % growth | 13.03M 155.99% | 11.308M | 1.722M | 15.23% |
| Q3 2021 Q2Q % growth | 5.53M 241.36% | 5.681M | -151K | -2.66% |
| Q2 2021 Q2Q % growth | 5.42M 359.32% | 4.366M | 1.054M | 24.14% |
| Q1 2021 Q2Q % growth | 3.07M 82.74% | 3.767M | -697K | -18.50% |
| Q4 2020 Q2Q % growth | 5.09M -40.19% | 2.578M | 2.512M | 97.44% |
| Q3 2020 Q2Q % growth | 1.62M -72.26% | 2.08M | -460K | -22.12% |
| Q2 2020 Q2Q % growth | 1.18M -84.22% | 1.566M | -386K | -24.65% |
| Q1 2020 Q2Q % growth | 1.68M -69.12% | 5.79M | -4.11M | -70.98% |
| Q4 2019 Q2Q % growth | 8.51M | 8.757M | -247K | -2.82% |
| Q3 2019 Q2Q % growth | 5.84M | 7.584M | -1.744M | -23.00% |
| Q2 2019 Q2Q % growth | 7.48M | 7.483M | -3K | -0.04% |
| Q1 2019 Q2Q % growth | 5.44M | 7.629M | -2.189M | -28.69% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -22.58% | 0% | 16.22% |
| Revenue | 0% | -8.2% | 0% | 6.65% |